Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for Methamphetamine Withdrawal
NCT04405193Phase 3Completed
- Start
- Oct 2019
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetylcysteine in Stimulant Withdrawal. Started Oct 2019; status: completed.
02
Drugs
acetylcysteine
03
Conditions
Stimulant Withdrawal
Beyond the preview
Go deeper on NCT04405193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04405193.